Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For NRDXF
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -0.22 0.97 0.97
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -97.16 -3.09 108.85
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.42 4.07 4.13
Cash -18.99 3.23 3.99
Capex 31.56 -0.14 -0.21
Free Cash Flow -21.20 -1.00 1.27
Revenue -21.77 6.66 8.51
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -16.66 0.06 0.07
Operating Margin -83.70 < 0.005 -0.03
ROA -53.37 < 0.005 < 0.005
ROE -57.14 -0.01 0.03
ROIC -97.90 < 0.005 0.18
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of NRDXF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of NRDXF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of NRDXF is permitted for members.